India to Brazil: Salbutamol Export Trade Route

The India to Brazil Salbutamol corridor is one of India's established pharmaceutical export routes, with 1,738 shipments documented worth a combined $38.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 63% of all export value, reflecting the consolidated nature of India's salbutamol manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $22.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with salbutamol's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 33.5%, placing it at rank #11 among India's top salbutamol export destinations globally.

On the import side, key buyers of Indian salbutamol in Brazil include LABORATORIO TEUTO BRASILEIRO S/A, LABORATORIO TEUTO BRASILEIRO S/A , LABORATORIO TEUTO BRASILEIRO S A and 20 others. LABORATORIO TEUTO BRASILEIRO S/A is the single largest importer with 822 shipments valued at $15.3M USD.

India's salbutamol exports to Brazil are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 1,135 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , GLENMARK PHARMACEUTICALS LIMITED — together account for 96% of total trade value on this route. The average shipment value of $22.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as aerodini hfa inhaler (salbutamol pressurised inhalation 100mcg) (1 x200 md) . and aerodini hfa inhaler (salbutamol sulphate 100mcg), suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LABORATORIO TEUTO BRASILEIRO S/A is the largest importer with 822 shipments worth $15.3M USD — representing 40% of all salbutamol imports from India on this route. A total of 23 buyers are active on this corridor.